Dallas, Texas – Lambert-Eaton myasthenic syndrome (LEMS) is a rare autoimmune disorder affecting the neuromuscular junction. The immune system produces autoantibodies against presynaptic P/Q-type voltage-gated calcium channels (VGCCs) on motor nerve terminals. When a nerve impulse arrives, these antibodies reduce calcium entry into the nerve terminal, limiting the release of...

SAN DIEGO, Calif. — Neurocrine Biosciences, Inc. (Nasdaq: NBIX) today announced the launch of educational resources designed to help healthcare providers strengthen their understanding of classic congenital adrenal hyperplasia. The offerings include bootCAHmp®, an interactive, educational course that builds foundational clinical knowledge, and DiscoverCAH™, a virtual patient case experience that enables healthcare providers to apply...

NAARDEN, Netherlands & WALTHAM, Mass. & BARCELONA, Spain —Prilenia Therapeutics B.V. and Ferreri today announced the publication online, on October 22, 2026, of a new manuscript, in Neurology®, the medical journal of the American Academy of Neurology, presenting a post hoc analysis providing Phase 3 clinical trial evidence of the association between...